Call for application 40th cycle

Bando ordinario


Educational goals and objectives

IINNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS
The international PhD Program in "Innovation in immuno-mediated and hematological disorders" aims at promoting the transfer of the knowledge in the field of immunology and hematology from basic to clinical research. It will rely on experimental integrated and innovative experimental approaches and scientific collaborations with international research institutes and Universities, both in Europe and in the USA.
The "Innovation in Immunology and Immunopathology" curriculum focuses on the study of molecular and cellular mechanisms underlying in innate and adaptive immunity in both physiological and pathological conditions, such as autoimmune and inflammatory diseases and primary immunodeficiencies. Particular attention will be paid on the knowledge of innate and adaptive immune responses involved in the mechanisms of resistance to micro-organisms and tumors.
The "Innovation in Hematology" curriculum explores the different biological aspects of hematological pathologies in children and in adults, with a particular focus on a more detailed characterization of hemopathological malignancies (including leukemia, lymphoma, myeloma) and on the diagnosis and therapy by the use of innovative technologies and strategies.

Specifiche economiche

Tipologia 1: DM629
Transizione digitale Generiche Pubblica Amministrazione Patrimonio culturale
0 0 0 0

Tipologia 2: DM630 Tipologia 3: Partenariati estesi Tipologia 4: Enti terzi ed Eccellenza Tipologia 5: Sapienza
1 0 2 9

Senza borsa
3

Themes, curriculum and specific competence


Borse ex D.M. 630: 1


Borse ENTI TERZI, PARTENARIATI ESTESI, ECCELLENZA


Tematica:
Ente finanziatore: ISTITUTO PASTEUR ITALIA FONDAZIONE CENCI BOLOGNETTI
Competenze richieste: nessuna competenza specifica richiesta

Tematica:
Sul curriculum: INNOVATION IN HEMATOLOGY

Ente finanziatore: ROMAIL VANESSA VERDECCHIA ODV
Competenze richieste: nessuna competenza specifica richiesta


Admission Procedure

Qualifications assessment Evaluation criteria for the admission exam to the International PHD Program in “INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS”
(40 cycle)
The evaluation of the qualifications, research project, and oral examination will be based on the hereby evaluation grids as follows:
1. Professional titles (max 15 points)

1.1 Master degree mark (max 5 points)

Mark Points
110, 110 e lode 5
109 -108 4
107 -106 3
105 -104 2
103 -102 1
<102 0

For the students who will defend the thesis after the oral examination but before October 31, 2024, the evaluation of master degree will based on the arithmetic mean of the exam scores.



Arithmetic mean Points
29 - 30 5
28 – 28.99 4
27 - 27.99 3
26 - 26.99 2

25 - 25.99 1
<25 0




1.2 Publications (max 7 points)

Description Points
Publications ISI (first author) 5
Publications ISI (co-author) 2
Book chapter 1
Abstract 0.5

1.3 Research experience (max 3 points)

Description Points
Stages at least, two months including Erasmus) in national/international research institutions 1.5
Research fellowship 1
Education courses 0.5


Oral interview Evaluation criteria for the admission exam to the International PHD Program in “INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS”
(40 cycle)

THE ORAL EXAM

1. Discussion on the submitted project : (max 60 points)

According to the PhD selection procedure, the candidate should present a research project that shows his/her aptitude to research activities as well as his/her ability to autonomously plan and organize the different phases of the project itself.
The project should not exceed 8000 characters (including blanks).

The project should be written in English according to the following scheme:

- Title;

- General purpose and aims of the project;

- Experimental procedures;

- References.
The project proposed for the competitive represent an obligation to conduct research activity during the PhD on this topics for the selected candidates.
The minimum score to be admitted to the PhD program is 40/60 points.

The 60 points of the project will be assigned as follows:

Knowledge of the state of the art (max 15 points)

Originality and innovation (max 15 points)

Clarity and completeness of the proposed objectives, methodologies and potential results (max 15 points)

Feasibility and relevance of the project with the PhD objectives (max 15 points)

The minimum score to pass the selection is:
Titles up to 15
Oral up to 60 (minimum 40)


language INGLESE


contacts and info https://phd.uniroma1.it/web/concorso38.aspx?i=3543 paola.dirusso@uniroma1.it 0649255107

Curriculum studiorum

Graduation date and grade of the Master's degree
detailed list of exams including completion dates and scores of Masters's degree
History of Scholarships, Research Grants (or similar)
Certificates of participation in post-graduate university courses
certificates of Participation in internships
Other University Awards/Degrees (e.g.: awards in competition, second degree)

Required documentation

§ research project
mandatory, the file must be uploaded within le ore 23:59 del 20/06/2024

§ List of publications
optional, the file must be uploaded within le ore 23:59 del 20/06/2024

§ other document: Research experiences (if any)
optional, the file must be uploaded within le ore 23:59 del 20/06/2024

Language Skills

the candidate must know the following languages
ENGLISH

Exam Schedule

Qualifications assessment
day04/07/2024
notesnone
publication on notice boardNO
publication on the web siteYes
web sitehttps://phd.uniroma1.it/web/INNOVATION-IN-IMMUNO-MEDIATED-AND-HEMATOLOGICAL-DISORDERS_nD3543.aspx
date of publication12/07/24
contacts0649255107

Oral interview
day18/07/2024
notesnone
time09:00
classroomaula 101 Palazzina D
addressViale Regina Elena 295
publication on notice boardNO
publication on the web siteYes
web sitehttps://phd.uniroma1.it/web/INNOVATION-IN-IMMUNO-MEDIATED-AND-HEMATOLOGICAL-DISORDERS_nD3543.aspx
date of publication24/07/2024
contacts0649255107


Day of publication of the final outcome: 24/07/2024

Evaluation scale

Qualifications assessment english version

Oral interview english version

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma